AGP Executive Report
Last update: 4 hours agoHIV Brain Research: Rutgers Health and Weill Cornell Medicine won $3 million from the National Institute of Mental Health to study how HIV affects the brain and to build actionable neuroHIV biomarkers. Cancer Care Update: Elevar Therapeutics says the FDA approved LYRFIGTU (lirafugratinib) for second-line cholangiocarcinoma with FGFR2 fusion or other rearrangements, with availability expected by Q4 2026. Mental Health & Medication: A Journal of Clinical Psychiatry study suggests alternative maintenance dosing strategies for paliperidone palmitate could help people with schizophrenia manage treatment more flexibly. Public Health Watch: CDC is investigating 37 hepatitis A cases in four states tied to imported frozen clams, with 30 hospitalizations reported. Community Health & Environment: Save the Sound’s 2026 Long Island Sound report card finds water quality improved or stable across most regions, with the Eastern Narrows rated B. Workforce Training: County College of Morris is launching a paid apprenticeship model for data science and AI training with a U.S. Department of Labor grant.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.